These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9773228)

  • 1. Successful paroxetine treatment of major depression in an adult form of metachromatic leukodystrophy with cognitive disturbances.
    Vella G; Loriedo C; Raccah R; Baldassarre P; Paolillo A
    Can J Psychiatry; 1998 Sep; 43(7):748-9. PubMed ID: 9773228
    [No Abstract]   [Full Text] [Related]  

  • 2. Paxil (paroxetine) lifts depression, lowers associated anxiety symptoms.
    Adv Nurse Pract; 1997 Oct; 5(10):71. PubMed ID: 9459990
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy in treatment-resistant depression.
    Malhi GS; Farmer AE
    Br J Psychiatry; 1999 Oct; 175():390-1. PubMed ID: 10789311
    [No Abstract]   [Full Text] [Related]  

  • 4. Paroxetine treatment of trichotillomania in an adolescent.
    Block C; West SA; Baharoglu B
    J Child Adolesc Psychopharmacol; 1998; 8(1):69-71. PubMed ID: 9639081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance-P antagonists: a new treatment for depression?
    Nutt D
    Lancet; 1998 Nov; 352(9141):1644-6. PubMed ID: 9853433
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical practice guidelines for depression in young people.
    Jureidini JN; Tonkin AL
    Med J Aust; 2003 Mar; 178(6):300; author reply 300-2. PubMed ID: 12633493
    [No Abstract]   [Full Text] [Related]  

  • 7. Depressing misrepresentation?
    Newton J; Langlands A
    Lancet; 2004 May; 363(9422):1732. PubMed ID: 15158640
    [No Abstract]   [Full Text] [Related]  

  • 8. The paroxetine controversy: lessons for ketamine trials.
    Zhang MW; Ho RC
    Lancet Psychiatry; 2015 Dec; 2(12):1057-8. PubMed ID: 26613847
    [No Abstract]   [Full Text] [Related]  

  • 9. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.
    Bourin M
    Hum Psychopharmacol; 2003 Apr; 18(3):185-90. PubMed ID: 12672169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
    Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
    JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of SSRI-induced akathisia after switch to nefazodone.
    Chelben J; Strous RD; Lustig M; Baruch Y
    J Clin Psychiatry; 2001 Jul; 62(7):570-1. PubMed ID: 11488371
    [No Abstract]   [Full Text] [Related]  

  • 15. [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
    Strobel M; Warnke A; Roth M; Schulze U
    Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):279-89. PubMed ID: 15565897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
    Weihs KL; Settle EC; Batey SR; Houser TL; Donahue RM; Ascher JA
    J Clin Psychiatry; 2000 Mar; 61(3):196-202. PubMed ID: 10817105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine in major depression.
    Jureidini J; Tonkin A
    J Am Acad Child Adolesc Psychiatry; 2003 May; 42(5):514; author reply 514-5. PubMed ID: 12707552
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
    Ushiroyama T; Ikeda A; Ueki M
    J Med; 2004; 35(1-6):151-62. PubMed ID: 18084873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine and its uses in psychiatry.
    Bell C; Nutt D
    Hosp Med; 1999 May; 60(5):353-6. PubMed ID: 10396411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.